Rituximab ( Rituxan sup > ) is a monoclonal antibody that is widely used for lymphoma.

利妥西单抗 ( 美罗华 ) 是广泛应用于淋巴瘤的单克隆抗体.

互联网

Patients get rituximab through infusion into a vein ( IV ) at the oncologist's office or clinic.

患者可在肿瘤专家的办公室或门诊接受 静脉 注入美罗华.

互联网

Objective: To elucidate the efficacy and adverse drug reaction of rituximab in treatment of non - Hodgkin's lymphoma.

目的: 阐述利妥昔单抗对于 非 霍奇金淋巴瘤的疗效和药物的不良反应,并尝试探讨其药物经济学.

互联网